MedPath

ociceptive processing in anterior cutaneous nerve entrapment syndrome, a quantitative sensory testing analysis

Completed
Conditions
buikwand aandoening
entrapped nerve in abdominal wall
Registration Number
NL-OMON38839
Lead Sponsor
niversitair Medisch Centrum Sint Radboud
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
70
Inclusion Criteria

1. Patient has been diagnosed with abdominal complaints, matching ACNES:
i) Patient had a constant site of tenderness that is superficially located with a small (<2cm2) area of maximal tenderness.
ii) The most intense pain could be localized with the tip of one finger.
iii) Tenderness increased by abdominal muscle tensing (Carnett*s test).
2. has been treated (successfully and unsuccessfully) for ACNES.
3. Patient is at least 18 years old on the day the informed consent form will be signed.
4. Patient is willing and able to comply with the trial protocol.
5. Patient is able to speak, read and understand the local language of the investigational site, is familiar with the procedures of the study, and agrees to participate in the study program by giving oral and written informed consent prior to screening evaluations.

Exclusion Criteria

1. Abdominal complaints were due to a condition other than ACNES (e.g. pain related to scar tissue).
2. Patient has (a history of) another (chronic) pain syndrome that interferes with the interpretation of QST results.
3. Patient has (a history of) a medical disorder that interferes with the study measurements or may pose a risk for the patient.
4. Patient does not feel a pinprick test to the lower extremities, due to affected sensory input (e.g. neuropathy as a result of diabetes mellitus).
5. Female patient is pregnant during the course of the study.

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Pressure pain and electrical pain thresholds as investigated by QST. </p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Secondary study parameters are Visual Analog Scale (VAS) scores and results of<br /><br>Pain Anxiety Symptom Scale (PASS) and Pain Catastrophizing Scale (PCS)<br /><br>questionnaires.</p><br>
© Copyright 2025. All Rights Reserved by MedPath